Tag: Prescription Drugs

Displaying 1 - 3 of 3 results.

Filtering by content type: Public Event

The Hatch-Waxman Act, passed by Congress more than 30 years ago, provides a regulatory and judicial framework to expedite generic entry into U.S. prescription drug markets. For many drugs, the Act has succeeded in lowering patent-related barriers to generic drug entry, thereby...
The Federal Trade Commission held a workshop to explore competition issues involving biologic medicines and follow-on biologics. As described in the Federal Register Notice, the workshop focused on a few key issues, inter alia:
The Federal Trade Commission hosted a one-day public workshop to examine competition and consumer protection issues in the pet medications industry. The quality and cost of pet medications is an important pocketbook issue for many consumers. In 2011, 62 percent of U.S. households...